IXHL

Incannex HealthcareF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-03

View Chart

Current thesis

Composite grade F from latest DB weights. Momentum 3.7 / Value 57.0

Posture

Defensive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -0.1.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

0 · Net Neutral

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-06-03

Fundamentals

As of 2026-06-02 • Vendor: Data Vendor v1

Scores

As of 2026-06-03 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-06-03

Supporting evidence

What

Grade F · Defensive

Confidence Medium · Net Neutral

Why

Momentum4 · Δ7d -4.3

Value57 · Δ7d -0.1

SentimentN/A · Δ7d -

So what

Weak posture (Net Neutral). Prioritize risk control and patience.

Lead driver: Value · See fundamentals

Momentum

52% active weight

Current posture

7d trendSoftening

Δ7d

-4.3

Δ21d

-22.9

Value

48% active weight

Current posture

7d trendFlat

Δ7d

-0.1

Δ21d

-0.2

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade F. Momentum 3.7 / Value 57.0

Fundamentals (TTM)

As of 2026-06-02

Market Cap

$36.49M

Beta

2.59

Shares Out

346.23M

P/E (TTM) · Derived

-0.0

P/S (TTM)

11428.33

P/FCF (TTM) · Derived

-0.58

Rev YoY

-100.0%

EPS YoY

+93.3%

Gross Margin

Op Margin

-215008.3%

Net Debt

-$15.04M

Current Ratio

47.51

As of 2026-06-03 • Updated nightlySource: Internal modelMethodology